Search
for
Sort by
Research 301–330 of 1000+
- Transforming growth factor-β in stem cells and tissue homeostasis
- Stem cell dynamics, migration and plasticity during wound healing
- Cutaneous signs in COVID ‐19 patients: A review
- Cutaneous complications of chemotherapeutic agents
- Sic Transit Gloria: Farewell to the Epidermal Transit Amplifying Cell?
- Alopecia areata
- K <sub>ATP</sub> Channels and Cardiovascular Disease
- Lupus erythematosus: systemic and cutaneous manifestations
- Protoporphyrin IX: the Good, the Bad, and the Ugly
- Epithelial Skin Biology
- Significant Correction of Disease after Postnatal Administration of Recombinant Ectodysplasin A in Canine X-Linked Ectodermal Dysplasia
- Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management
- Epidemiology, Diagnosis, and Treatment of Atopic Dermatitis in the Developing Countries of Asia, Africa, Latin America, and the Middle East: A Review
- Beyond Expectations
- Emerging nonmetabolic functions of skin fat
- Essential syphilitic alopecia revisited
- Oral Retinoids in Dermatology
- Autoimmunity and autoimmune co-morbidities in psoriasis
- Paraneoplastic alopecia associated with internal malignancies in the cat
- Trichohyalin: Presence in the Granular Layer and Stratum Corneum of Normal Human Epidermis
- Endocrine-skin interactions
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Toxic shock syndrome: Recent developments in pathogenesis
- Alternative uses of dermoscopy in daily clinical practice: An update
- The distributions of type IV collagen .ALPHA. chains in basement membranes of human epidermis and skin appendages
- Pregnancy and the Skin
- Syphilis: A great imitator
- Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area
- Cutaneous Lesions in Systemic Lupus Erythematosus
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology